NCT02484833
Erbitux MEtastatic Colorectal Cancer Strategy Study treatment 3 completed NCT04572451
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma treatment 1 recruiting NCT05030077
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma treatment 2 unknown_status NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT05814224
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA No drug interventions other Not Available recruiting NCT05288166
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) treatment 3 active_not_recruiting NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT01991691
Tablet-based Patient Reported Outcome No drug interventions supportive_care Not Available completed NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC treatment 2 recruiting NCT05964101
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma treatment 2 recruiting NCT00541801
Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography No drug interventions diagnostic Not Available completed NCT06535568
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB No drug interventions treatment Not Available not_yet_recruiting NCT03711110
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) No drug interventions prevention Not Available recruiting NCT03284255
Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study No drug interventions treatment Not Available unknown_status NCT03403777
Avelumab in Refractory Testicular Germ Cell Cancer. treatment 2 completed NCT04922047
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) treatment 1 / 2 unknown_status NCT02468245
Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Setting? No drug interventions supportive_care Not Available unknown_status NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT04518852
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC treatment 2 completed NCT01316458
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy treatment 2 completed NCT04962958
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery prevention 2 not_yet_recruiting NCT04807166
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer treatment 2 active_not_recruiting NCT01169792
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients Not Available Not Available completed NCT03606369
Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. prevention 2 / 3 unknown_status NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT04309084
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma treatment 1 active_not_recruiting NCT04002284
Anlotinib in Metastatic HER2 Negative Breast Cancer treatment 2 completed NCT02151981
AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT04961307
Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab Not Available Not Available unknown_status NCT04962425
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients Not Available Not Available unknown_status